Overexpression of MiR-633 Suppresses the Tumorigenicity of Gastric Cancer Cells and Induces Apoptosis by Targeting MAPK1

Abstract

Objective

MicroRNA (miRNA/miR)-633 is dysregulated in several types of cancers and is involved in tumorigenesis. However, the function and role of this miRNA in gastric cancer (GC) are not fully understood. The aim of the present study was to evaluate miR-633 expression in GC cell lines and in GC tissue vs. adjacent normal tissue, and to determine its association with clinicopathological data. This work was extended to investigate the effects of miR-633 overexpression on tumor cells in vitro.

Methods

Reverse transcription-quantitative PCR (RT-qPCR) was used to detect and compare the expression level of miR-633 in GC cells, as well as in GC and normal adjacent tissue samples. The clinical significance of miR-633 was also analyzed. MiR-633 lentivirus (LV-miR-633) and negative control lentivirus (LV-NC) were generated and used to transduce SGC-7901 and HGC-27 GC cells in order to analyze the effect of miR-633 on their phenotype. The effects of miR-633 overexpression on GC cell proliferation, apoptosis, migration and invasion were investigated. The target gene of miR-633 was predicted, then confirmed using a dual luciferase reporter gene assay, RT-qPCR and Western blotting.

Results

MiR-633 was significantly downregulated in GC cell lines, as well as in GC tissue compared with adjacent normal tissue. Moreover, miR-633 expression was associated with the tumor/node/metastasis (TNM) stage, invasion depth, Borrmann classification and lymph node metastasis (P<0.05). Compared with the LV-NC group, transduction with LV-miR-633 reduced the proliferation, the number of clones, the wound healing rate, the number of invading cells and the number of cells in the G₁ phase of the cell cycle (P<0.01). LV-miR-633 also increased the apoptosis rate (P<0.01). The expression level of mitogen-activated protein kinase (MAPK) 1, high-mobility group box 3 (HMGB3), claudin 1 (CLDN1) and MAPK13 were downregulated in LV-miR-633-transduced cells (P<0.01). The dual luciferase reporter assay confirmed that the 3′-untranslated region of MAPK1 was the target site of miR-633 (P<0.01).

Conclusion

MiR-633 acts as a tumor suppressor in GC, and its expression level is associated with TNM stage, invasion depth, Borrmann type and lymph node metastasis. Overexpression of miR-633 inhibits the proliferation and migration of GC cells and induces apoptosis and cell cycle arrest at the in G₁ phase. In addition, miR-633 negatively regulates the expression of MAPK1, HMGB3, CLDN1 and MAPK13 and directly targets MAPK1.

Keywords

miR-633 / gastric cancer / apoptosis / metastasis / mitogen-activated protein kinase 1

References

[1] ZhangZ, LiZ, LiY, et al.. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther, 2014, 21(8): 305-316

[2] LiL, ZhuX, ShouT, et al.. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway. Mol Med Rep, 2018, 17(3): 4003-4010

[3] ZhouX, MenX, ZhaoR, et al.. miR-200c inhibits TGF-beta-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer. Cancer Gene Ther, 2018, 25(3–4): 68-76

[4] XuW, YangZ, LuN. Molecular targeted therapy for the treatment of gastric cancer. J Exp Clin Cancer Res, 2016, 35(1): 1-11

[5] da Silva OliveiraKC, Thomaz AraújoTM, AlbuquerqueCI, et al.. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World J Gastroenterol, 2016, 22(35): 7951-7962

[6] ZhangH, QuY, DuanJ, et al.. Integrated analysis of the miRNA, gene and pathway regulatory network in gastric cancer. Oncol Rep, 2016, 35(2): 1135-1146

[7] HuML, ZhuSX, XiongSW, et al.. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review). Oncol Rep, 2019, 41(3): 1439-1454

[8] HuangYW, SunGP, LiuJT. miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1. Onco Targets Ther, 2016, 9: 1623-1633

[9] BobowiczM, SkrzypskiM, CzapiewskiP, et al.. Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer. Clin Exp Metastasis, 2016, 33(8): 765-773

[10] LiQ, ChengQ, ChenZ, et al.. MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-beta1. Oncol Rep, 2016, 35(2): 1125-1134

[11] YehCH, MolesR, NicotC. Clinical significance of microRNAs in chronic and acute human leukemia. Mol Cancer, 2016, 15(1): 37

[12] PangX, ZhouZ, YuZ, et al.. Foxo3a-dependent miR-633 regulates chemotherapeutic sensitivity in gastric cancer by targeting Fas-associated death domain. RNA Biol, 2019, 16(2): 233-248

[13] LiYM, ShiB, LiX, et al.. Study of the characteristics of gastric carcinoma in Wuwei City of Gansu province. Zhonghua Putong Waike Zazhi (Chinese), 2004, 13(9): 667-669

[14] ZhangZY, WuZQ, WangHJ, et al.. An Analysis of Gastric Cancer Detection and Epidemicity in High Incidental Area with Gastric Cancer, Wuwei City, Gansu Province. China Cancer, 2009, 18(10): 814-817

[15] ShiDB, MaRR, ZhangH, et al.. GAGE7B promotes tumor metastasis and growth via activating the p38delta/pMAPKAPK2/pHSP27 pathway in gastric cancer. J Exp Clin Cancer Res, 2019, 38(1): 124

[16] TanFL, OoiA, HuangD, et al.. p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion. Int J Cancer, 2010, 126(10): 2353-2361

[17] EftangLL, EsbensenY, TannaesTM, et al.. Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival. BMC Cancer, 2013, 13(1): 586-586

[18] IravaniO, TayBW, ChuaPJ, et al.. Claudins and gastric carcinogenesis. Exp Biol Med (Maywood), 2013, 238(4): 344-349

[19] LiuY, WangL, LinXY, et al.. Anti-apoptotic effect of claudin-1 on TNF-alpha-induced apoptosis in human breast cancer MCF-7 cells. Tumour Biol, 2012, 33(6): 2307-2315

[20] ZhengW, YangJ, DongZ, et al.. High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma. Cancer Manag Res, 2018, 10: 5979-5989

[21] LiX, WuY, LiuA, et al.. MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3. Biochem Biophys Res Commun, 2016, 477(4): 768-773

[22] GuoS, WangY, GaoY, et al.. Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells. Med Sci Monit, 2016, 22: 3951-3960